A carregar...
Monitoring Molecular Response in Chronic Myeloid Leukemia
BACKGROUND: Prior to the advent of tyrosine kinase inhibitor (TKI) therapy, the evaluation of hematologic and cytogenetic responses was sufficient to gauge treatment efficacy in patients with chronic myeloid leukemia. However, with more potent TKI therapies, the majority of patients achieve complete...
Na minha lista:
| Publicado no: | Cancer |
|---|---|
| Main Authors: | , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
2010
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4969001/ https://ncbi.nlm.nih.gov/pubmed/20960522 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cncr.25527 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|